Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma

Molecular and Cellular Biochemistry

Volumn 383, Issue 1-2, 2013, Pages 49-58

  Chen, Ping ^a   Zhao, Xia ^a   Ma, Liang ^a  

^a Fourth Affiliated Hospital   (China)

Author keywords

Hepatocellular carcinoma; MicroRNA 100; Non coding RNA; Polo like kinase 1; Prognosis; Small interfering RNA

Indexed keywords

MICRORNA 100; POLO LIKE KINASE 1;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; TUMOR RECURRENCE; UPREGULATION;

AGED; APOPTOSIS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING;

EID: 84885428640     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1753-0     Document Type: Article

References (32)

1. McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15:223-243
2. Yuen MF, Hou JL, Chutaputti A et al (2009) Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 24:346-353
3. Nelson P, Kiriakidou M, Sharma A et al (2003) The microRNA world: small is mighty. Trends Biochem Sci 28:534-540
4. Subramanian S, Steer CJ (2010) MicroRNAs as gatekeepers of apoptosis. J Cell Physiol 223:289-298
5. Berardi E, Pues M, Thorrez L et al (2012) miRNAs in ESC differentiation. Am J Physiol Heart Circ Physiol 303:H931-H939
6. Roy S, Sen CK (2012) miRNA in wound inflammation and angiogenesis. Microcirculation 19:224-232
7. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6:590-610
8. Braconi C, Henry JC, Kogure T (2011) The role of microRNAs in human liver cancers. Semin Oncol 38:752-763
9. Negrini M, Gramantieri L, Sabbioni S et al (2011) microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem 11:500-521
10. Oliveira JC, Brassesco MS, Morales AG et al (2011) MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells. Asian Pac J Cancer Prev 12:3001-3004
11. Liu J, Lu KH, Liu ZL et al (2012) MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer 12:519
12. Zheng YS, Zhang H, Zhang XJ et al (2012) MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 31:80-92
13. Petrelli A, Perra A, Schernhuber K et al (2012) Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an earlyevent maintained along tumor progression. Oncogene 31:4517-4526
14. Tovar V, Alsinet C, Villanueva A et al (2010) IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol 52:550-559
15. Shi W, Alajez NM, Bastianutto C et al (2010) Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 126:2036-2048
16. Peng DX, Luo M, Qiu LW et al (2012) Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Oncol Rep 27:1238-1244
17. Carthew RW (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16:203-208
18. Lee S, Vasudevan S (2013) Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol 768:97-126
19. Osman A (2012) MicroRNAs in health and disease-basic science and clinical applications. Clin Lab 58:393-402
20. Roberts AP, Lewis AP, Jopling CL (2011) The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 102:101-139
21. El Tayebi HM, Hosny KA, Esmat G et al (2012) MiR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Lett 586:3309-3316
22. Zhang L, Yang L, Liu X et al (2013) MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein through nuclear factor kappa B pathways. Hepatology 57:1919-1930
23. Zhang Y, Wei W, Cheng N et al (2012) Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56:1631-1640
24. Zhang LY, Liu M, Li X et al (2013) miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem 288:4035-4047
25. Furuta M, Kozaki K, Tanimoto K et al (2013) The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One 8:e60155
26. Yau WL, Lam CS, Ng L et al (2013) Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS One 8:e57882
27. Wang S, Xue S, Dai Y et al (2012) Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer. Diagn Pathol 7:159
28. Wang G, Chen L, Meng J et al (2013) Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma. Int Urol Nephrol 45:373-379
29. Liu XS, Song B, Liu X (2010) The substrates of Plk1, beyond the functions in mitosis. Protein Cell 1:999-1010
30. Pellegrino R, Calvisi DF, Ladu S et al (2010) Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 51:857-868
31. He ZL, Zheng H, Lin H et al (2009) Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients. World J Gastroenterol 15:4177-4182
32. He Z, Wu J, Dang H et al (2011) Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression. Cancer Lett 303:92-98